155 related articles for article (PubMed ID: 26351841)
1. Use of Genome Engineering to Create Patient Specific MLL Translocations in Primary Human Hematopoietic Stem and Progenitor Cells.
Breese EH; Buechele C; Dawson C; Cleary ML; Porteus MH
PLoS One; 2015; 10(9):e0136644. PubMed ID: 26351841
[TBL] [Abstract][Full Text] [Related]
2.
Schneidawind C; Jeong J; Schneidawind D; Kim IS; Duque-Afonso J; Wong SHK; Iwasaki M; Breese EH; Zehnder JL; Porteus M; Cleary ML
Blood Adv; 2018 Apr; 2(8):832-845. PubMed ID: 29650777
[TBL] [Abstract][Full Text] [Related]
3. MLL leukemia induction by genome editing of human CD34+ hematopoietic cells.
Buechele C; Breese EH; Schneidawind D; Lin CH; Jeong J; Duque-Afonso J; Wong SH; Smith KS; Negrin RS; Porteus M; Cleary ML
Blood; 2015 Oct; 126(14):1683-94. PubMed ID: 26311362
[TBL] [Abstract][Full Text] [Related]
4. ZFP521 regulates murine hematopoietic stem cell function and facilitates MLL-AF9 leukemogenesis in mouse and human cells.
Garrison BS; Rybak AP; Beerman I; Heesters B; Mercier FE; Scadden DT; Bryder D; Baron R; Rossi DJ
Blood; 2017 Aug; 130(5):619-624. PubMed ID: 28615219
[TBL] [Abstract][Full Text] [Related]
5. Learning from mouse models of MLL fusion gene-driven acute leukemia.
Schwaller J
Biochim Biophys Acta Gene Regul Mech; 2020 Aug; 1863(8):194550. PubMed ID: 32320749
[TBL] [Abstract][Full Text] [Related]
6. CRISPR Gene Editing of Murine Blood Stem and Progenitor Cells Induces MLL-AF9 Chromosomal Translocation and MLL-AF9 Leukaemogenesis.
Sarrou E; Richmond L; Carmody RJ; Gibson B; Keeshan K
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32549410
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic transformation in the absence of MLL1/KMT2A: distinctions in target gene reactivation.
Chen Y; Ernst P
Cell Cycle; 2019 Jul; 18(14):1525-1531. PubMed ID: 31161857
[TBL] [Abstract][Full Text] [Related]
8. Ligand-independent FLT3 activation does not cooperate with MLL-AF4 to immortalize/transform cord blood CD34+ cells.
Montes R; Ayllón V; Prieto C; Bursen A; Prelle C; Romero-Moya D; Real PJ; Navarro-Montero O; Chillón C; Marschalek R; Bueno C; Menendez P
Leukemia; 2014 Mar; 28(3):666-74. PubMed ID: 24240202
[TBL] [Abstract][Full Text] [Related]
9. Quercetin alters the DNA damage response in human hematopoietic stem and progenitor cells via TopoII- and PI3K-dependent mechanisms synergizing in leukemogenic rearrangements.
Biechonski S; Gourevich D; Rall M; Aqaqe N; Yassin M; Zipin-Roitman A; Trakhtenbrot L; Olender L; Raz Y; Jaffa AJ; Grisaru D; Wiesmuller L; Elad D; Milyavsky M
Int J Cancer; 2017 Feb; 140(4):864-876. PubMed ID: 27813122
[TBL] [Abstract][Full Text] [Related]
10. Dietary flavonoids induce MLL translocations in primary human CD34+ cells.
Barjesteh van Waalwijk van Doorn-Khosrovani S; Janssen J; Maas LM; Godschalk RW; Nijhuis JG; van Schooten FJ
Carcinogenesis; 2007 Aug; 28(8):1703-9. PubMed ID: 17468513
[TBL] [Abstract][Full Text] [Related]
11. MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment.
Ugale A; Säwén P; Dudenhöffer-Pfeifer M; Wahlestedt M; Norddahl GL; Bryder D
Oncogene; 2017 Jun; 36(22):3207-3212. PubMed ID: 28068328
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells
Reimer J; Knöß S; Labuhn M; Charpentier EM; Göhring G; Schlegelberger B; Klusmann JH; Heckl D
Haematologica; 2017 Sep; 102(9):1558-1566. PubMed ID: 28572162
[TBL] [Abstract][Full Text] [Related]
13. MLL translocations, histone modifications and leukaemia stem-cell development.
Krivtsov AV; Armstrong SA
Nat Rev Cancer; 2007 Nov; 7(11):823-33. PubMed ID: 17957188
[TBL] [Abstract][Full Text] [Related]
14. MLL-TET1 fusion protein promotes immortalization of myeloid progenitor cells and leukemia development.
Kim HS; Oh SH; Kim JH; Kim JY; Kim DH; Lee SJ; Choi SU; Park KM; Ryoo ZY; Park TS; Lee S
Haematologica; 2017 Nov; 102(11):e434-e437. PubMed ID: 28798069
[No Abstract] [Full Text] [Related]
15. ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia.
Germano G; Morello G; Aveic S; Pinazza M; Minuzzo S; Frasson C; Persano L; Bonvini P; Viola G; Bresolin S; Tregnago C; Paganin M; Pigazzi M; Indraccolo S; Basso G
Oncotarget; 2017 Apr; 8(16):26129-26141. PubMed ID: 28412727
[TBL] [Abstract][Full Text] [Related]
16. Environmental and chemotherapeutic agents induce breakage at genes involved in leukemia-causing gene rearrangements in human hematopoietic stem/progenitor cells.
Thys RG; Lehman CE; Pierce LC; Wang YH
Mutat Res; 2015 Sep; 779():86-95. PubMed ID: 26163765
[TBL] [Abstract][Full Text] [Related]
17. Bioflavonoids promote stable translocations between MLL-AF9 breakpoint cluster regions independent of normal chromosomal context: Model system to screen environmental risks.
Bariar B; Vestal CG; Deem B; Goodenow D; Ughetta M; Engledove RW; Sahyouni M; Richardson C
Environ Mol Mutagen; 2019 Mar; 60(2):154-167. PubMed ID: 30387535
[TBL] [Abstract][Full Text] [Related]
18. MLL rearrangements are induced by low doses of etoposide in human fetal hematopoietic stem cells.
Moneypenny CG; Shao J; Song Y; Gallagher EP
Carcinogenesis; 2006 Apr; 27(4):874-81. PubMed ID: 16377807
[TBL] [Abstract][Full Text] [Related]
19. Mll fusions generated by Cre-loxP-mediated de novo translocations can induce lineage reassignment in tumorigenesis.
Drynan LF; Pannell R; Forster A; Chan NM; Cano F; Daser A; Rabbitts TH
EMBO J; 2005 Sep; 24(17):3136-46. PubMed ID: 16096649
[TBL] [Abstract][Full Text] [Related]
20. PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.
Li Z; Chen P; Su R; Hu C; Li Y; Elkahloun AG; Zuo Z; Gurbuxani S; Arnovitz S; Weng H; Wang Y; Li S; Huang H; Neilly MB; Wang GG; Jiang X; Liu PP; Jin J; Chen J
Cancer Res; 2016 Feb; 76(3):619-29. PubMed ID: 26747896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
